Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Jose Mas Prio
Introduction
Jose Mas Prio is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target the 5-HT7 receptor. His work is essential for advancing treatments for various central nervous system disorders.
Latest Patents
Jose Mas Prio holds a patent for 5-HT7 receptor antagonists. This invention relates to compounds that exhibit pharmacological activity towards the 5-HT7 receptor. Specifically, it focuses on tetrahydroisoquinoline substituted sulfonamide compounds. The patent also covers the processes for preparing these compounds, pharmaceutical compositions that include them, and their applications in treating diseases associated with serotonin (5-HT) involvement.
Career Highlights
He is currently associated with Laboratorios del Dr. Esteve S.A., where he continues to innovate in the pharmaceutical sector. His work has the potential to impact the treatment of CNS disorders significantly.
Collaborations
Jose has collaborated with esteemed colleagues such as Antoni Torrens Jover and Susana Yenes Minguez. Their combined expertise enhances the research and development efforts within their organization.
Conclusion
Jose Mas Prio's contributions to pharmacology and his innovative patent for 5-HT7 receptor antagonists highlight his role as a key figure in advancing medical treatments. His work continues to pave the way for new therapeutic options in the field of neuroscience.